NR 293 Pharmacology for Nursing
Practice
Exam 1: Objective Assessment Final
Practice Questions and Solutions
Practice Questions with Detailed Rationales
New 2026 Update —— 100% Correct Verified Solutions
Chamberlain University
Question 1: Which of the following best describes pharmacokinetics?
A.The study of how drugs affect the body
B. The study of how the body absorbs, distributes, metabolizes,
and excretes drugs ✓
C. The study of drug interactions with cellular receptors
D. The study of adverse drug reactions and toxicity
Rationale: Pharmacokinetics is the study of what the body does to a drug,
encompassing the four processes of absorption, distribution, metabolism, and
excretion (ADME). Understanding pharmacokinetics allows nurses to predict
drug concentrations at the site of action, determine appropriate dosing
intervals, and anticipate potential drug interactions. In contrast,
pharmacodynamics studies what the drug does to the body, including receptor
, interactions and dose-response relationships. Both disciplines are essential for
safe and effective medication administration.
Question 2: A patient is taking a drug that is a substrate of the
cytochrome P450 3A4 enzyme. If the patient begins taking a known
CYP3A4 inhibitor, what effect would be expected?
A.Decreased therapeutic effect of the substrate drug
B.Increased metabolism and decreased levels of the substrate drug
C. Increased levels and potential toxicity of the substrate drug ✓
D. No change in the substrate drug levels
Rationale: A CYP3A4 inhibitor reduces the metabolic activity of the CYP3A4
enzyme, leading to decreased metabolism of substrate drugs that depend on
this enzyme for breakdown. This results in increased plasma levels of the
substrate drug, which can lead to enhanced therapeutic effects or, more
commonly, toxicity. Common CYP3A4 inhibitors include ketoconazole,
erythromycin, and grapefruit juice. Nurses should monitor for signs of drug
toxicity when a CYP inhibitor is added to a patient's regimen and anticipate
possible dose adjustments.
Question 3: What is the meaning of a drug's half-life (t1/2)?
A.The time it takes for a drug to reach its peak concentration in the blood
B. The time it takes for the plasma concentration of a drug to
decrease by half ✓
C. The duration of time a drug produces its therapeutic effect
D. The time required for a drug to be completely eliminated from the
body
Rationale: The half-life of a drug is the time required for the plasma
concentration of the drug to decrease by 50% after distribution equilibrium is
reached. It takes approximately 4-5 half-lives for a drug to reach steady state
with repeated dosing, and the same 4-5 half-lives for a drug to be essentially
eliminated after the last dose.
Understanding half-life is critical for determining dosing intervals and
predicting when steady-state concentrations will be achieved. Drugs with short
half-lives require more frequent dosing, while drugs with long half-lives can be
, dosed less frequently.
Question 4: A drug with a high first-pass effect is prescribed orally. What
does this mean for the patient?
A.The drug will have enhanced therapeutic effects when taken orally
B. A significant portion of the drug is metabolized by the liver
before reaching systemic circulation, reducing its bioavailability ✓
C. The drug will be excreted rapidly by the kidneys before it can act
D. The drug will accumulate in fatty tissues and have a prolonged effect
, Rationale: The first-pass effect (presystemic metabolism) occurs when a drug
is extensively metabolized by the liver or gut wall before it reaches systemic
circulation after oral administration. This significantly reduces the drug's
bioavailability, meaning that only a fraction of the administered dose reaches
the systemic circulation. Drugs with high first-pass metabolism (e.g.,
propranolol, morphine, lidocaine) may require much higher oral doses
compared to parenteral doses to achieve the same therapeutic effect.
Alternative routes of administration (sublingual, transdermal, intravenous) can
bypass the first-pass effect and improve bioavailability.
Question 5: Which route of drug administration bypasses the first-pass
effect?
A.Oral
B.Sublingual
C. Rectal (lower hemorrhoidal vein absorption)
D. Both B and C ✓
Rationale: Both sublingual and certain rectal routes can partially or fully
bypass the first-pass effect. Sublingual administration allows the drug to be
absorbed through the oral mucosa directly into the systemic circulation via the
superior vena cava, completely bypassing the portal circulation and hepatic
first-pass metabolism. Rectal administration can also partially bypass first-pass
metabolism because the lower and middle hemorrhoidal veins drain into the
systemic circulation rather than the portal system. However, the upper
hemorrhoidal veins do drain into the portal system, so rectal administration
only partially avoids first-pass metabolism. Oral administration is most subject
to the first-pass effect.
Question 6: What is the therapeutic index (TI) of a drug?
A.The ratio between the minimum effective dose and the maximum tolerated
dose
B. The ratio between the lethal dose and the therapeutic dose,
indicating drug safety ✓
C. The time required for a drug to reach therapeutic levels in the blood
D. The cost-effectiveness ratio of a drug compared to alternatives
Practice
Exam 1: Objective Assessment Final
Practice Questions and Solutions
Practice Questions with Detailed Rationales
New 2026 Update —— 100% Correct Verified Solutions
Chamberlain University
Question 1: Which of the following best describes pharmacokinetics?
A.The study of how drugs affect the body
B. The study of how the body absorbs, distributes, metabolizes,
and excretes drugs ✓
C. The study of drug interactions with cellular receptors
D. The study of adverse drug reactions and toxicity
Rationale: Pharmacokinetics is the study of what the body does to a drug,
encompassing the four processes of absorption, distribution, metabolism, and
excretion (ADME). Understanding pharmacokinetics allows nurses to predict
drug concentrations at the site of action, determine appropriate dosing
intervals, and anticipate potential drug interactions. In contrast,
pharmacodynamics studies what the drug does to the body, including receptor
, interactions and dose-response relationships. Both disciplines are essential for
safe and effective medication administration.
Question 2: A patient is taking a drug that is a substrate of the
cytochrome P450 3A4 enzyme. If the patient begins taking a known
CYP3A4 inhibitor, what effect would be expected?
A.Decreased therapeutic effect of the substrate drug
B.Increased metabolism and decreased levels of the substrate drug
C. Increased levels and potential toxicity of the substrate drug ✓
D. No change in the substrate drug levels
Rationale: A CYP3A4 inhibitor reduces the metabolic activity of the CYP3A4
enzyme, leading to decreased metabolism of substrate drugs that depend on
this enzyme for breakdown. This results in increased plasma levels of the
substrate drug, which can lead to enhanced therapeutic effects or, more
commonly, toxicity. Common CYP3A4 inhibitors include ketoconazole,
erythromycin, and grapefruit juice. Nurses should monitor for signs of drug
toxicity when a CYP inhibitor is added to a patient's regimen and anticipate
possible dose adjustments.
Question 3: What is the meaning of a drug's half-life (t1/2)?
A.The time it takes for a drug to reach its peak concentration in the blood
B. The time it takes for the plasma concentration of a drug to
decrease by half ✓
C. The duration of time a drug produces its therapeutic effect
D. The time required for a drug to be completely eliminated from the
body
Rationale: The half-life of a drug is the time required for the plasma
concentration of the drug to decrease by 50% after distribution equilibrium is
reached. It takes approximately 4-5 half-lives for a drug to reach steady state
with repeated dosing, and the same 4-5 half-lives for a drug to be essentially
eliminated after the last dose.
Understanding half-life is critical for determining dosing intervals and
predicting when steady-state concentrations will be achieved. Drugs with short
half-lives require more frequent dosing, while drugs with long half-lives can be
, dosed less frequently.
Question 4: A drug with a high first-pass effect is prescribed orally. What
does this mean for the patient?
A.The drug will have enhanced therapeutic effects when taken orally
B. A significant portion of the drug is metabolized by the liver
before reaching systemic circulation, reducing its bioavailability ✓
C. The drug will be excreted rapidly by the kidneys before it can act
D. The drug will accumulate in fatty tissues and have a prolonged effect
, Rationale: The first-pass effect (presystemic metabolism) occurs when a drug
is extensively metabolized by the liver or gut wall before it reaches systemic
circulation after oral administration. This significantly reduces the drug's
bioavailability, meaning that only a fraction of the administered dose reaches
the systemic circulation. Drugs with high first-pass metabolism (e.g.,
propranolol, morphine, lidocaine) may require much higher oral doses
compared to parenteral doses to achieve the same therapeutic effect.
Alternative routes of administration (sublingual, transdermal, intravenous) can
bypass the first-pass effect and improve bioavailability.
Question 5: Which route of drug administration bypasses the first-pass
effect?
A.Oral
B.Sublingual
C. Rectal (lower hemorrhoidal vein absorption)
D. Both B and C ✓
Rationale: Both sublingual and certain rectal routes can partially or fully
bypass the first-pass effect. Sublingual administration allows the drug to be
absorbed through the oral mucosa directly into the systemic circulation via the
superior vena cava, completely bypassing the portal circulation and hepatic
first-pass metabolism. Rectal administration can also partially bypass first-pass
metabolism because the lower and middle hemorrhoidal veins drain into the
systemic circulation rather than the portal system. However, the upper
hemorrhoidal veins do drain into the portal system, so rectal administration
only partially avoids first-pass metabolism. Oral administration is most subject
to the first-pass effect.
Question 6: What is the therapeutic index (TI) of a drug?
A.The ratio between the minimum effective dose and the maximum tolerated
dose
B. The ratio between the lethal dose and the therapeutic dose,
indicating drug safety ✓
C. The time required for a drug to reach therapeutic levels in the blood
D. The cost-effectiveness ratio of a drug compared to alternatives
